RNAM - Avidity Biosciences Inc


0   0%

Share volume: 0
Last Updated:
Pharmaceutical Products/Pharmaceutical Preparations: 3.19%

PREVIOUS CLOSE
CHG
CHG%

N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 12-31-2025
Fiscal Quarter Q4 2025
Report Date 02-23-2026
Total revenue 860.000 K
Cost of revenue 0.000
Gross profit 860.000 K
     
Operating expenses 255.338 M
Selling general and admin 88.742 M
Research and development 166.596 M
Total expenses 255.338 M
     
Operating income -254.478 M
Ebit -254.955 M
Pretax income -237.101 M
     
Income tax 0.000
Net income basic 0.000
     
Net income -237.101 M